CD28 and sarcoma: Long et al studied the incorporation of OX40 and CD28 costimulatory domains in GD2-specific CAR T cells and found that they mediated efficient and comparable lysis of both GD2+ sarcoma and neuroblastoma cell lines in vitro [50].